PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
08-May-2023 SynCrest Launches CRDMO Service for Peptide-based Therapeutics Businesswire
08-May-2023 Laronde Announces New Leadership Businesswire
08-May-2023 Incyte Strengthens Research & Development Efforts Appointing Pablo J. Cagnoni, M.D. to New Leadership Role Businesswire
08-May-2023 MWI Animal Health Unveils Updated and Expanded PetPage® Patient Portal Businesswire
08-May-2023 Legend Biotech Corporation Announces Pricing of Registered Direct Offering of $350 Million of American Depositary Shares Businesswire
08-May-2023 Cigniti Wins "Best IoT Healthcare Platform" in the 2023 MedTech Breakthrough Awards Program Businesswire
08-May-2023 Temple Therapeutics Reveals Breakthrough Findings on Ovarian Cancer at AACR 2023 Businesswire
08-May-2023 Reveal Lasers Announces Acquisition of Med Rep Meeting Newswire
08-May-2023 MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update Businesswire
08-May-2023 Life Biosciences and Forge Biologics Announce cGMP Manufacturing Partnership to Advance Development of Novel Gene Therapies for Aging-Related Diseases Businesswire
08-May-2023 AceLink Therapeutics Appoints Pedro Huertas, M.D., Ph.D., as Chief Medical Officer Businesswire
08-May-2023 Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference Businesswire
08-May-2023 CinRx Portfolio Company CinDome Pharma Presents Encouraging Data on Deudomperidone (CIN-102) at 2023 Digestive Disease Week® Conference Businesswire
08-May-2023 Rallybio to Present at the JMP Securities 2023 Life Sciences Conference Businesswire
08-May-2023 Invacare Holdings Corporation Completes Financial Restructuring and is Well Positioned to Drive Forward in its Transformation Businesswire
08-May-2023 Seres Therapeutics and Nestlé Health Science Present Results from ECOSPOR IV Phase 3 Study of VOWST™, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection, at the Digestive Disease Week (DDW) Annual Meeting Businesswire
08-May-2023 Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China Businesswire
08-May-2023 Tema, Backed by Index, Accel and Zinal, Expands Access to Innovative Investment Themes Through Launch of Active ETF Platform Businesswire
08-May-2023 ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance Businesswire
08-May-2023 KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop Businesswire